Literature DB >> 15379769

Overview of psoriasis.

Menno A de Rie1, Amber Y Goedkoop, Jan D Bos.   

Abstract

Psoriasis is a chronic disease that affects the skin and joints. Clinical hallmarks comprise erythematous plaques covered by silvery scaling and a chronic recurrent course. Histologically, psoriasis is characterized by the hyperproliferation of the epidermis, elongated and prominent blood vessels and a thick perivascular lymphocytic infiltrate. Psoriasis is now considered an auto-immune disease. Although many different therapies are available, there is clearly a need for new treatments. Our improvement of understanding of the pathogenesis of psoriasis together with the possibility to develop bioactive proteins ("biologicals") targeted at specific steps in the pathogenesis of psoriasis, have opened a new field of promising future treatments. In the development and assessment of new therapeutical modalities for psoriasis, a clear definition of a patient's psoriasis severity is essential. The impact of a given therapy can only then be evaluated, based on the changes in the severity score during and after application of the treatment. Copyright 2004 Blackwell Publishing, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15379769     DOI: 10.1111/j.1396-0296.2004.04037.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  11 in total

1.  Regulatory role for Krüppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.

Authors:  Gen Nakanishi; Yong-Sik Kim; Takeshi Nakajima; Anton M Jetten
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

2.  Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris.

Authors:  Lin Gao; Hong Li; Kai Li; Zhu Shen; Ling Liu; Chunying Li; Zhengdong Zhang; Yufeng Liu
Journal:  Genet Mol Biol       Date:  2009-01-10       Impact factor: 1.771

3.  Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.

Authors:  Ozer Arican; Murat Aral; Sezai Sasmaz; Pinar Ciragil
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

4.  Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy.

Authors:  Katerina Kondelkova; Lenka Borska; Ctirad Andrys; Jan Krejsek; Kvetoslava Hamakova; Simona Rendarova; Vit Rehacek; Jan Kremlacek; Zdenek Fiala
Journal:  Mediators Inflamm       Date:  2015-06-08       Impact factor: 4.711

5.  Keratin 76 is required for tight junction function and maintenance of the skin barrier.

Authors:  Tia DiTommaso; Denny L Cottle; Helen B Pearson; Holger Schlüter; Pritinder Kaur; Patrick O Humbert; Ian M Smyth
Journal:  PLoS Genet       Date:  2014-10-23       Impact factor: 5.917

6.  Biological markers in the etiology of psoriasis: Targeted treatment options.

Authors:  Catia de Felice; Georgiana Clare Marulli; Marco Ardigò; Enzo Berardesca
Journal:  Biologics       Date:  2007-03

7.  Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders.

Authors:  Richard D Bennett; Mark R Pittelkow; Emanuel E Strehler
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

8.  The expression of syndecan-1 in psoriatic epidermis.

Authors:  Davor Tomas; Majda Vucić; Mirna Situm; Bozo Kruslin
Journal:  Arch Dermatol Res       Date:  2008-04-02       Impact factor: 3.017

9.  Serum level of antibody against benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in people dermally exposed to PAHs.

Authors:  Lenka Borska; Ctirad Andrys; Jan Krejsek; Vladimir Palicka; Marcela Chmelarova; Kvetoslava Hamakova; Jan Kremlacek; Pavel Borsky; Zdenek Fiala
Journal:  J Immunol Res       Date:  2014-04-13       Impact factor: 4.818

10.  Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation.

Authors:  Lenka Borska; Ctirad Andrys; Jan Krejsek; Vladimir Palicka; Marcela Chmelarova; Kvetoslava Hamakova; Jan Kremlacek; Zdenek Fiala
Journal:  Oxid Med Cell Longev       Date:  2014-08-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.